United Health Products, Inc.
About United Health Products, Inc.
United Health Products, Inc. (UEEC) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, and designed to absorb exudate/drainage from superficial wounds and helps control bleeding. UEEC is focused on identifying new markets and applications for its product as well as ramping up sales in its current markets. For more on United Health Products, Inc. visit: www.unitedhealthproductsinc.com.
UEEC Security Details
| Market Value1 || $16,300,445 || a/o Jun 18, 2014 |
| Shares Outstanding || 102,647,640 || a/o Apr 15, 2014 |
| Float || 82,554,000 || a/o Dec 31, 2012 |
| Authorized Shares || 150,000,000 || a/o Mar 31, 2013 |
| Par Value || No Par Value |
Who we are...
United Health Products develops, manufactures, and markets innovative products based on our proprietary hemostatic gauze core technology. Our products are distributed under the brand name HemoStyp®, and other private label names, to the trauma, dental, dialysis, and veterinary markets.
We are customer driven. We distribute our products worldwide and support our partners with ideas and solutions that will help them manage the health and safety of the people they serve. United Health Products is based in Westbury, New York and
our common stock trades under the symbol “UEEC". More about our company...
What we do...
We produce HemoStyp®, a bio-absorbable sterile gauze that will promote hemostasis almost instantly when applied to a cut or open wound. It is a patented hemostatic agent registered with the FDA to help control bleeding.
HemoStyp® contains no harmful chemicals, additives, or animal by-products and is easily removed from the wound with water or saline without compromising coagulation.
HemoStyp® is available in multiple sizes and configurations
to help control most types of bleeding including: abrasions, lacerations, and major cuts; nose bleeds; dental surgeries;
post dialysis treatment; and puncture wounds. More about our products...
HemoStyp® is a water soluable hemostatic gauze that will produce hemostasis almost instantly when placed on a cut or open wound.
It does not contain harmful chemicals or animal by-products and is FDA registered to help stop bleeding. Once bleeding has stopped, HemoStyp® is easily removed from the wound with water or saline solution without compromising hemostasis.
HemoStyp® is extremely effective, inexpensive, and easy to use.
It is hypoallergenic and bacteriostatic and is available in multiple sizes and configurations to suit various needs and applications.
United Health Products, Inc. (UEEC) was formed to develop, produce, and market proprietary wound care products. Our core technology is a hemostatic gauze that provides the means to control bleeding from cuts and open wounds with a cost effective, high efficiency product.
This innovative technology is derived from regenerated oxidized cellulose and marketed under the trade name HemoStyp®. It is an effective, all natural hemostatic agent registered with the FDA to help control bleeding from open wounds and body cavities.
HemoStyp® is available in multiple sizes and configurations to suit various market segments and, in a healthcare sector shifting toward providing high quality care at affordable cost, offers an appealing alternative to higher priced competitive products. In addition to general military and civilian applications, the company has recently introduced Hemostyp® to the sports medicine, veterinary, dental surgery and dialysis markets.
UEEC's Chairman and CEO, Dr. Phillip Forman, has over 30 years of experience in wound care management. He leads an experienced executive management team with proven ability to develop, integrate, and grow brands in the healthcare industry. Under Dr. Forman's leadership the company will focus on market expansion, distribution, and brand awareness through:
• New contracts and strategic partnerships
• Effectively targeted marketing and advertising
• Sales excellence
• Outstanding customer support
• Key acquisitions and
• Innovative product development
We have added new configuations of our patented hemostatic gauze to our product line. The products were developed to address the specific needs of new market segments and of our existing customers, including the U.S. Military. The new products include:
Dental Gauze for oral surgery,
Four versions of Trauma Gauze™ for battlefield trauma, and
Two island dressings to support intravenous procedures.
We expect tangible contributions from all of these products as well as from the cumulative effect of an expanded product line. We will continue to identify and develop new products and configurations as we explore new markets and inundate existing ones.